65,437 trials
Lymphoma
Primary: Event-free Survival After 12 Months — 78 percentage of participants
Osteoarthritis, Knee
Primary: Blood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)] — NA; NA; NA Z-score
Zirconia Based Fixed Dental Prostheses
Primary: Number of Fixed Dental Prostheses (FDPs) With Failure — 0; 1 FDPs with failure
Lung Cancer
Primary: 8-Week Disease Control Rate (Complete Response, Partial Response and Stable Disease) — 33 percentage of participants
Malaria
Primary: OZ439 Cmax — 672; 1720; 1870 ng/mL
Malaria
Primary: OZ439 AUC(0-168h) — 8780; 10300; 9460 ng*h/mL
Sexually Transmitted Diseases
Primary: Number of Patients Recording Preferences to Restrict Provider Access to Some or All Electronic Health Record (EHR) Data — 45; 13 participants
Leukemia
Primary: Complete Response Rate — 4 participants
Carotid Stenosis
Primary: Number of Patients With Required Supplementation of Local Anesthetic by Surgeon — 13; 13 participants — p=1.0
Severe Sepsis
Primary: F2-isoprostanes After 72 Hours of Acetaminophen or Placebo — 33.4; 40.15 pg/mL — p=0.353
Persistent Allergic Asthma
Primary: Change From Baseline in Mean Morning Peak Expiratory Flow (PEF) Following the 24-week Treatment Period — 27.03; 18.18 L/min
Kidney Transplant · Kidney Transplant Recipient · Graft Function/Survival
Primary: During Screening Phase: Incidence of Alloantibody Development — 79 participants
Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma · Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 · Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7
Primary: Overall Response Rate — 6; 2; 8; 1 participants
Periodontal Diseases · Dental Plaque · Dental Calculus
Primary: Gingival Index — 0.7190; 1.1152 units on a scale
Non-small Cell Lung Cancer (NSCLC)
Primary: Occurrence of Postoperative Air Leaks — 45.8; 67.9; 88.9 percentage of participants